A novel 111In-labeled antisense DNA probe with multi-chelating sites (MCS-probe) showing high specific radioactivity and labeling efficiency

Nuclear Medicine and Biology

Volumn 26, Issue 1, 1999, Pages 17-21

  Fujibayashi, Yasuhisa ^a   Yoshimi, Eiji ^a   Waki, Atsuo ^c   Sakahara, Harumi ^b   Saga, Tsuneo ^b   Konishi, Junji ^b   Yonekura, Yoshiharu ^c   Yokoyama, Akira ^c  

^a Grad Sch Pharmaceutical Sci   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Antisense; High specific radioactivity; Indium 111; Oncogene mRNA

Indexed keywords

COMPLEMENTARY DNA; EDETIC ACID; INDIUM 111; ISOTHIOCYANIC ACID DERIVATIVE; DRUG DERIVATIVE; INDIUM; ISOTHIOCYANOBENZYL ETHYLENEDIAMINE TETRACETIC ACID; MESSENGER RNA; ONCOPROTEIN;

ARTICLE; BINDING AFFINITY; CHELATION; CONFORMATIONAL TRANSITION; DNA PROBE; DRUG DNA BINDING; GENE TARGETING; GENE TECHNOLOGY; ISOTOPE LABELING; ONCOGENE C ERB; PROTO ONCOGENE; METABOLISM; NUCLEIC ACID PROBE; SYNTHESIS;

ANTISENSE ELEMENTS (GENETICS); DNA, ANTISENSE; EDETIC ACID; INDIUM RADIOISOTOPES; ISOTHIOCYANATES; ISOTOPE LABELING; ONCOGENE PROTEINS; RNA, MESSENGER;

EID: 0032589007     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00058-4     Document Type: Article

References (13)

1. Crooke R.M. In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Anti-Cancer Drug Res. 6:1991;609-646.
2. Dewanjee M.K., Ghafouripour A.K., Kapadvanjwala M., Mewanjee S., Serafini A.N., Lopez D.M., Sfakianakis G.N. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J. Nucl. Med. 35:1994;1054-1063.
3. 111In labeled antisense oligonucleotide for tumor imaging. Kaku-Igaku. 33:1996;115-122.
4. Grooteclaes M., Pasleau F., Dijkmans H., Berzi P., Albert A., Winkler-Gol R. The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines. Cancer Res. 54:1994;4193-4199.
5. Hnatowich D.J., Winnard P. Jr, Virzi F., Fogarasi M., Sano T., Smith C.L., Cantor C.R., Rusckowski M. Technetium-99m labeling of DNA oligonucleotides. J. Nucl. Med. 36:1995;2306-2314.
6. Höltke H.J., Seibl R., Burg J., Mühlegger K., Kessler C. Non-radioactive labeling and detection of nucleic acids II. Optimization of the digoxigenin system. Biol. Chem. Hoppe-Seyler. 371:1990;929-938.
7. Kessler C., Höltke H.J., Seibl R., Burg J., Mühlegger K. Non-radioactive labeling and detection of nucleic acids I. A novel DNA labeling and detection system based on digoxigenin:anti-digoxigenin ELISA pronciple (Digoxigenin system). Biol. Chem. Hoppe-Seyler. 371:1990;917-927.
8. Langer F.R., Waldrop A.A., Ward D.C. Enzymatic synthesis of biotin-labeled polynucleotides Novel nucleic acid affinity probes . Proc. Natl. Acad. Sci. USA. 78:1981;6633-6637.
9. Matteucci M.D., Wagner R.W. In pursuit of antisense. Nature. 384:(suppl.):1996;20-22.
10. Mühlegger K., Huber E., von der Eltz H., Rüger R., Kessler C. Non-radioactive labeling and detection of nucleic acids IV. Synthesis and properties of digoxigenin-modified 2′-deoxyuridine-5′-triphosphates and a photoactivatable analog of digoxigenine (photodigoxigenin). Biol. Chem. Hoppe-Seyler. 371:1990;953-965.
11. Piwnica-Worms D. Making sense out of anti-sense Challenges of imaging gene translation with radiolabeled oligonucleotides . J. Nucl. Med. 35:1994;1064-1066.
12. Seibl R., Höltke H.J., Rüger R., Meindl A., Zachau H.G., Rabhofer R., Roggendorf M., Wolf H., Arnold N., Wienberg J., Kessler C. Non-radioactive labeling and detection of nucleic acids III. Applications of the digoxigenin system. Biol. Chem. Hoppe-Seyler. 371:1990;939-951.
13. Yakubov L., Deeva E.A., Zarytova V.F., Ivanova E.M., Ryte A.S., Yurchenko L.V., Vlassov V.V. Mechanism of oligonucleotide uptake by cells Involvement of specific receptors? Proc. Natl. Acad. Sci. USA. 86:1989;6454-6458.